Phase I study of ZEN-008 (AN-152), a targeted cytotoxic LHRH analog, in female patients with cancers expressing LHRH receptors
Emons, G., Kaufmann, M., Günthert, A. R., Hamid-Werner, M., Gründker, C., Loibl, S., Schally, A. V.
Published in Journal of clinical oncology (20.06.2006)
Published in Journal of clinical oncology (20.06.2006)
Get full text
Journal Article